Table 4 Risk factors for death.
Uni-variable HR (95% CI) | P value | Multivariable HR (95% CI) | P value | |
---|---|---|---|---|
Clinical covariates | ||||
Age, years | 1.07 (1.06–1.08) | <0.001 | 1.04 (1.03–1.06) | <0.001 |
Female sex (vs male) | 0.35 (0.26–0.48) | <0.001 | .. | .. |
Smoking history (vs nonsmoking) | 2.43 (1.59–3.73) | <0.001 | 1.84 (1.17–2.92) | 0.009 |
Health care provider (vs non health care provider) | 0.24 (0.06–0.96) | 0.044 | .. | .. |
Comorbidity (Yes/No) | ||||
ASCVD | 2.56 (1.90–3.45) | <0.001 | .. | .. |
Diabetes | 2.47 (1.82–3.34) | <0.001 | .. | .. |
Hypertension | 2.21 (1.68–2.90) | <0.001 | .. | .. |
Cancer | 2.59 (1.58–4.26) | <0.001 | .. | .. |
Symptoms and complications (Y/N) | ||||
Dyspnea | 6.26 (4.76–8.24) | <0.001 | .. | .. |
Wet cough | 1.63 (1.24–2.14) | 0.001 | .. | .. |
ARDS | 54.21 (37.13–79.14) | <0.001 | .. | .. |
Bacterial infections | 18.36 (12.16–27.72) | <0.001 | .. | .. |
Temperature at admission (°C) | 1.50 (1.28–1.75) | <0.001 | 1.32 (1.07–1.64) | 0.009 |
Laboratory covariates | ||||
Neutrophils ×10E + 9/L | 1.23 (1.20–1.26) | <0.001 | .. | .. |
Lymphocytes x10E + 9/L | 0.07 (0.05–0.10) | <0.001 | .. | .. |
Log10 NLR | 1.06 (1.06–1.07) | <0.001 | 3.30 (2.10–5.19) | <0.001 |
Platelets x10E + 9/L | 0.99 (0.99–1.00) | <0.001 | 0.996 (0.994–0.998) | 0.001 |
hCRP, mg/L | 1.02 (1.02–1.02) | <0.001 | .. | .. |
Procalcitonin, ng/ml | 1.23 (1.18–1.28) | <0.001 | .. | .. |
LDH, U/L | 1.00 (1.00–1.00) | <0.001 | .. | .. |
Ferritin, ng/ml | 1.00 (1.00–1.00) | <0.001 | .. | .. |
aPTT, s | 1.06 (1.04–1.08) | <0.001 | 1.04 (1.02–1.05) | <0.001 |
Log10 D-dimer, mg/L | 1.09 (1.08–1.11) | <0.001 | 3.00 (2.17–4.16) | <0.001 |
Total bilirubin, μmol/L | 1.03 (1.03–1.04) | <0.001 | .. | .. |
Creatine kinase, U/L | 1.00 (1.00–1.00) | <0.001 | .. | .. |
Troponin I, ng/L | 1.00 (1.00–1.00) | <0.001 | .. | .. |
BUN, mmol/L | 1.06 (1.05–1.07) | <0.001 | .. | .. |
Log10 Scr, μmol/L | 1.00 (1.00–1.00) | <0.001 | 4.55 (2.72–7.62) | <0.001 |
IL-6 | 1.00 (1.00–1.00) | <0.001 | .. | .. |
IL-10 | 1.00 (1.00–1.00) | 0.004 | .. | .. |
CD3-positive, % | 0.95 (0.93–0.97) | <0.001 | .. | .. |
CD8-positive, % | 0.91 (0.88–0.94) | <0.001 | .. | .. |
CD4/CD8 ratio | 1.27 (1.18–1.37) | <0.001 | .. | .. |